Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
17/05/2025
Daiwa Securities: Maintains a buy rating on Schlumberger (SLB.US), adjusting from a buy rating to a hold rating, with a target price adjusted from $50.00 to $45.00.
Latest
8 m ago
Market news: Nissan is preparing to close its two factories in Japan, namely the Zama Plant and the Shonan Plant of its subsidiary Nissan Motor Body. Nissan is considering terminating automotive production at its factories in South Africa, India, and Argentina, and closing its two factories in Mexico.
10 m ago
Ming Sheng Company's MSCI Emerging Markets Foreign Exchange Index has risen for five consecutive weeks. The MSCI Emerging Markets Stock Index has increased by 3% to reach a new high since October 2024.
10 m ago
Mingcheng Company's MSCI Emerging Markets Currency Index has risen for five consecutive weeks. The MSCI Emerging Markets Stock Index has increased by 3% overall, reaching a new high since October 2024.
11 m ago
Freight Technologies (FRGT.US): The revenue in Q1 of 2025 was $4.101 million, compared to the previous value of $4.288 million; the earnings per share were -$0.73, compared to the previous value of -$10.76.
14 m ago
CASI Pharmaceuticals (CASI.US): The Q1 financial report for 2025 achieved revenue of $6.24 million, up from the previous value of $3.409 million, and higher than the expected value of $6.1 million. Earnings per share were -$0.69, an improvement from the previous value of -$0.71, but lower than the expected value of -$0.60.
See all latest